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Abstract:
Two cases of suspected anaphylaxis occurred in our hospital within 2 
weeks of each other. The first, a 6-year 4-month-old Border Collie 
presented for thoracic wall resection. Once anaesthetised, 20mg/kg of 
intravenous cefuroxime (Zinacef 75mg/ml, GlaxoSmithKline UK, UK) was 
administered slowly for prophylactic antibiosis. Ten minutes after 
administration was completed – desaturation occurred alongside 
tachycardia, hypotension, and apnoea. Chest compliance was extremely 
poor, with minimal chest movement. Treatment included intermittent 
positive pressure ventilation, intravenous fluids, terbutaline, adrenaline, 
and dexamethasone. The second case, a 5-year 8-month old Lhasa Apso 
presented for elective orthopaedic surgery. Intravenous cefuroxime 
(Zinacef 75mg/ml, GlaxoSmithKline UK, UK) was again administered 
slowly for prophylactic antibiosis; however, it is uncertain whether the 
patient received the full dose of 20mg/kg. Mid administration 
tachycardia, tachypnoea, and hypotension occurred – alongside poor 
chest compliance. Cefuroxime administration was stopped, the fluid line 
disconnected and treatment with chlorphenamine given. 
 
Veterinary Record Case Reports
Page 1 of 10 Veterinary Record Case Reports
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Revised August 2017 Page 1 of 10
Submission template for full cases
All case reports MUST be submitted online using this Word template. Please refer to the Hints and Tips 
template so you know what to include in each section
o http://mc.manuscriptcentral.com/vetreccr
o You will be asked for more detailed information on submission where you can also upload 
images, multimedia files, etc
o Further details are available in the Instructions for authors 
For studies using client-owned animals the article must demonstrate a high standard (best practice) of 
veterinary care and have informed client consent
You, your practice or institution must be a subscriber to Veterinary Record Case Reports in order to 
submit. Subscribers can submit as many cases as they like, access all the published material, and re-use 
any published material for personal use and teaching without further permission. 
o For more information on rates and how to purchase your subscription visit 
http://vetrecordcasereports.bmj.com/site/about/Subslanding.xhtml
o Contact your librarian, head of department or practice owner to see if your institution 
already has a subscription
o
TITLE OF CASE Do not include “a case report”
Suspected anaphylaxis after intravenous administration of cefuroxime (Zinacef) in two dogs, 
with descriptions of arterial blood gas abnormalities over time.
SUMMARY Up to 150 words summarising the case presentation and outcome (this 
will be freely available online)
Two cases of suspected anaphylaxis occurred in our hospital within 2 weeks of each other. 
The first, a 6-year 4-month-old Border Collie presented for thoracic wall resection. Once 
anaesthetised, 20mg/kg of intravenous cefuroxime (Zinacef 75mg/ml, GlaxoSmithKline UK, 
UK) was administered slowly for prophylactic antibiosis. Ten minutes after administration 
was completed – desaturation occurred alongside tachycardia, hypotension and apnoea. 
Chest compliance was extremely poor, with minimal chest movement. Treatment included 
intermittent positive pressure ventilation, intravenous fluids, terbutaline, adrenaline and 
dexamethasone. The second case, a 5-year 8-month old Lhasa Apso presented for elective 
orthopaedic surgery. Intravenous cefuroxime (Zinacef 75mg/ml, GlaxoSmithKline UK, UK) 
was again administered slowly for prophylactic antibiosis; however, it is uncertain whether 
the patient received the full dose of 20mg/kg. Mid administration tachycardia, tachypnoea 
and hypotension occurred – alongside poor chest compliance. Cefuroxime administration was 
stopped, the fluid line disconnected and treatment with chlorphenamine given.
BACKGROUND Why you think this case is important – why did you write it up?
Anaphylaxis is a rare but potentially life threatening adverse event, and can occur in 
response to many commonly administered perioperative medications (1). A recent human 
national audit in the United Kingdom reported an incidence of perioperative anaphylaxis of 1 
in 10,000 anaesthetics, with the most common triggers being intravenous (IV) antibiotics 
(47%) and muscle relaxants (33%) (2). In veterinary patients, incidence of perioperative 
anaphylaxis is unknown. Numbers of reports of drug related anaphylaxis in the veterinary 
literature are small, reported suspected triggers include IV antibiotics(3-6), IV contrast 
agents (7, 8) IV buprenorphine (9), IV propofol emulsion (10), thiopentone (11, 12) and 
rocuronium (13). These are summarised in table 1. Due to the low number of reports of 
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perioperative anaphylaxis in veterinary medicine, we felt it was imperative to document 
these cases. This is the first detailed report of suspected anaphylaxis following 
administration of cefuroxime (Zinacef, GlaxoSmithKline) in two dogs. We hope this will raise 
awareness of the possibility of anaphylaxis under general anaesthesia, especially with a 
commonly used drug that may potentially be considered a safer choice than other 
intravenous antibiotics such as amoxicillin clavulanate (Augmentin, GlaxoSmithKline) (4) due 
to the current ratio of reports in the veterinary literature.
CASE PRESENTATION Presenting features, clinical and environmental history
Case 1: A six-year four-month old female neutered Border Collie weighing 19.8 kg presented 
for right thoracic wall and rib resection. Diagnostic CT imaging under general anaesthesia 
undertaken 6 days prior to surgery confirmed the presence of a soft tissue mass invading the 
twelfth and thirteenth intercostal spaces on the right side. No evidence of metastasis was 
seen. The dog was not on any current medication, and no other medical concerns were 
reported. Blood work (haematology, biochemistry and electrolytes) taken 6 days prior to 
surgery revealed mild elevations in glucose (5.6mmol/L; ref 3-5mmol/L), cholesterol 
(7.9mmol/L; ref 3.8-7mmol/L), and alkaline phosphatase (75U/L; ref 20-60U/L). All other 
results were within normal limits. On pre-anaesthetic examination, body condition score was 
deemed to be 7/9. Auscultation of the chest was unremarkable, no cardiac murmurs or 
arrhythmias detected and normal lung sounds audible bilaterally. The patient was panting, 
heart rate was 120 beats per minute with a synchronous metatarsal pulse, capillary refill 
time (CRT) was less than two seconds, and mucous membranes were pink. Pre-medication 
with 0.2mg/kg methadone (Comfortan 10mg/ml, Dechra Veterinary Products, UK) and 
3mcg/kg dexmedetomidine (Dexdomitor 0.5mg/ml, Vetoquinol UK Ltd, UK) was 
administered intramuscularly, and twenty minutes later an intravenous catheter placed in 
the right cephalic vein. Anaesthesia was induced with propofol to effect (PropoFlo Plus 
10mg/ml, Zoetis UK Ltd, UK), which totalled 38mg (1.9mg/kg). The trachea was intubated 
with a cuffed size 10.5mm endotracheal tube, and connected to a circle breathing system. 
Anaesthesia was maintained with isoflurane (IsoFlo 100%, Zoetis UK Ltd, UK) in oxygen, at 
a percentage required to provide suitable anaesthetic depth. A multi-parameter monitor 
(Datex-Ohmeda S/5 Compact) was used for anaesthetic monitoring which included ECG, 
pulse oximetry, capnography, and oscillometric blood pressure measurement (NIBP). 
Intravenous fluid therapy was started (Vetivex 11/Hartmanns, Dechra Veterinary Products, 
UK) at 4ml/kg/hr, and clipping of the surgical site began. Intravenous cefuroxime (Zinacef 
75mg/ml, GlaxoSmithKline UK, UK) at a dose of 20mg/kg was administered over ten 
minutes for prophylactic antibiosis. Immediately prior to the start of antibiotic administration 
HR was 55 beats per minute, respiratory rate 6 breaths per minute, mean arterial pressure 
72mmHg, SpO2 97% and ETCO2 51mmHg. An arterial line was placed in the left dorsal pedal 
artery for invasive blood pressure measurement, and for arterial blood gas sampling. A blood 
sample was collected for baseline packed cell volume and total protein prior to surgery (45% 
and 68g/L respectively) and for blood typing if required. Ten minutes after completion of 
cefuroxime administration, apnoea was noted. This was initially managed with intermittent 
manual ventilation, however desaturation quickly followed with SpO2 falling to from 98% to 
85% within 2 minutes. At this stage when manual ventilation was attempted, chest 
compliance was poor with minimal chest movement and no capnograph trace. Heart rate had 
increased from 55 beats per minute to 165 beats per minute, and oscillometric blood 
pressure, which had been reliably cycling at 5-minute intervals, was no longer reading. 
Manual ventilation continued, and although chest compliance still felt poor, a capnograph 
trace was visible after 8-10 breaths, showing a prolonged expiratory upstroke with EtCO2 of 
60-80mmHg. Oxygen saturation improved with manual ventilation, with SpO2 increasing to 
100%. Mucous membranes were dark pink in colour with CRT of 1 second. The first NIBP 
reading registered after the event was 10 minutes after the onset of clinical signs and gave 
MAP of 48 mmHg. This increased to and remained above 60 mmHg after treatment as 
described later.
Case 2: A five-year eight-month old female neutered Lhasa Apso weighing 7.9 kg presented 
for an elective surgical management of medial patella luxation. On pre-anaesthetic 
examination auscultation of the chest was unremarkable, with no cardiac murmurs or 
arrhythmias detected and normal lung sounds present bilaterally. Respiratory rate was 16 
breaths per minute and heart rate 88 beats per minute with synchronous good quality 
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pulses. Pre-medication with 0.2mg/kg methadone (Comfortan 10mg/ml, Dechra Veterinary 
Products, UK) and 10 mcg/kg acepromazine (Acecare 2mg/ml, Animalcare Limited, UK) was 
administered intravenously followed by induction of anaesthesia with propofol to effect 
(PropoFlo Plus 10mg/ml, Zoetis UK Ltd, UK), which totalled 36mg (4.5mg/kg). The trachea 
was intubated with a cuffed size 6mm endotracheal tube, and connected to a circle breathing 
system. Anaesthesia was maintained with isoflurane (IsoFlo 100%, Zoetis UK Ltd, UK) in 
oxygen, at a percentage required to provide suitable anaesthetic depth. A multi-parameter 
monitor (Datex-Ohmeda S/5 Compact) was used for anaesthetic monitoring as described 
previously. Intravenous fluid therapy was commenced (Vetivex 11/Hartmanns, Dechra 
Veterinary Products, UK) at 3ml/kg/hr, and clipping of the surgical site began. Intravenous 
cefuroxime (Zinacef 75mg/ml, GlaxoSmithKline UK, UK) at a dose of 20mg/kg was 
administered into the IV injection port of the giving set over twenty minutes for prophylactic 
antibiosis. Approximately ten minutes after cefuroxime had started to be administered, the 
respiration pattern changed to become shallow and rapid. Heart rate increased from 90 to 
185 beats per minute, chest compliance was subjectively poor, and NIBP recorded MAP of 45 
mmHg. At this point antibiotic administration was stopped, and the giving set disconnected 
from the patient and flushed through to remove any residual cefuroxime in the line. It was 
estimated the patient received approximately 10mg/kg of cefuroxime (half of the prescribed 
dose). 
INVESTIGATIONS If relevant
Case 1: Tracheal intubation was visually confirmed to rule out inadvertent extubation, and a 
positive glide sign seen on thoracic ultrasound ruled out pneumothorax. Three arterial blood 
gas samples were taken; these are presented in table 2. Sample A, taken twenty minutes 
after cefuroxime administration and immediately after terbutaline administration shows a 
marked mixed acidosis with a pH of 7.12. The most likely cause would be hypercapnia due to 
alveolar hypoventilation, and significantly reduced oxygen delivery potentially causing lactic 
acidosis. The A-a O2 gradient was high (309.7mmHg), with normal values in dogs expected 
to be less than 30mmHg when breathing room air (14) and less than 45mmHg in humans 
breathing 100% oxygen (15). Possible causes for this include ventilation perfusion (V/Q) 
mismatch, diffusion defect, or right to left shunting of blood. In this case, the most likely 
would be V/Q mismatch due to bronchoconstriction. Sample B, taken twenty minutes after 
sample A and following administration of adrenaline shows only mild improvement in acidosis 
and hypercapnia; however, the A-a O2 gradient was significantly improved along with PaO2. 
Such an improvement could be explained by rapid alleviation of severe bronchoconstriction 
by adrenaline (or a delayed action of terbutaline), reducing V/Q mismatch.  Sample C was 
taken 45 minutes after extubation, and approximately 1.5 hours post cefuroxime 
administration. The pH had returned to normal due to compensatory mechanisms for 
metabolic acidosis resulting in a low CO2 and low HCO3. The A-a O2 gradient had also 
normalised, however interestingly the patient was now hypokalaemic (K+ 2.8mmol/L). It is 
possible that this hypokalaemia could have been caused by beta-2 adrenergic agonism of 
terbutaline and epinephrine. 
DIFFERENTIAL DIAGNOSIS If relevant
Case 1: Once inadvertent endotracheal tube displacement or obstruction had been ruled out, 
a thoracic ultrasound ruled out pneumothorax. The ultrasound machine was set up in 
preparation for an ultrasound-guided nerve block so was the most rapid method of diagnosis 
as opposed to thoracic radiographs or thoracentesis. Bronchospasm – either idiopathic, due 
to underlying respiratory disease, or anaphylactic were the remaining differentials. With the 
presence of both respiratory and cardiovascular signs, anaphylaxis was suspected and 
treatment initiated.
TREATMENT If relevant 
Case 1: Treatment initially consisted of initiation of manual intermittent positive pressure 
ventilation, and 10ml/kg of intravenous fluids (Vetivex 11/Hartmanns, Dechra Veterinary 
Products, UK) administered over ten minutes. Terbutaline 0.01mg/kg (Bricanyl 0.5mg/ml, 
AstraZeneca UK Ltd, UK) was administered intramuscularly once bronchoconstriction was 
suspected. Oxygen saturation increased to 100%; however no response was seen in terms 
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of thoracic compliance. Therefore, five minutes later 0.005mg/kg of adrenaline (Adrenaline 
(epinephrine) 1 in 1000, Hameln pharmaceuticals ltd, UK) diluted in 1ml of fluids (Vetivex 
11/Hartmanns, Dechra Veterinary Products, UK) was administered intravenously over 2 
minutes. Immediately after adrenaline administration thoracic compliance was vastly 
improved and subjectively back to baseline levels. Dexamethasone 0.2mg/kg (Colvasone 
0.2%, Norbrook Labratories Ltd, UK) was administered intravenously prior to recovery from 
anaesthesia in an attempt to reduce the risk of a biphasic reaction, however evidence for this 
is still unclear (16). Potassium (Potassium chloride concentrate 15%, Hameln 
pharmaceuticals ltd, UK) was supplemented in intravenous fluids (Vetivex 11/Hartmanns, 
Dechra Veterinary Products, UK) until normokalaemia was restored.
Case 2: In the second case treatment consisted of 4mg chlorphenamine IV (Chlorphenamine 
maleate 10mg/ml, Wockhardt UK Ltd, UK), after which chest compliance subjectively 
returned to baseline levels, HR reduced to 75 beats per minute and MAP increased to 85 
mmHg. The respiratory rate remained elevated at 25-30 breaths per minute so intermittent 
positive pressure ventilation was initiated. Desaturation did not occur in this case, and due to 
improvement of clinical signs – surgery proceeded.
OUTCOME AND FOLLOW-UP
Case 1: Approximately 40 minutes after initial clinical signs were seen, the patient passed a 
large about of mucoid diarrhoea with fresh blood present. This was suspected to be a 
consequence of anaphylaxis due to the direct effect of histamine on the gastrointestinal 
mucosa, with diarrhoea being one of the symptoms listed on the World Allergy Organisation 
(WAO) grading system (17). At this point concern over pulmonary function was discussed 
between the anaesthesia and surgical teams. The A-a O2 gradient was still very abnormal, 
and with the planned thoracic wall resection likely to compromise pulmonary gas exchange 
further, the decision was made to postpone the elective procedure. Upon removal of the 
endotracheal tube, a small amount of pink coloured fluid of slightly foamy consistency was 
noted at the distal end of the tube. The patient recovered uneventfully from general 
anaesthesia, and stayed in ICU overnight for close monitoring. The arterial catheter was left 
in place for further arterial samples to be taken as necessary and sample C taken 45 minutes 
post extubation shows a normal A-a O2 gradient.
The dog was anaesthetised the following day for the planned thoracic wall resection, and no 
adverse events occurred. The anaesthetic protocol is detailed in table 3. Differences included 
7mg of chlorphenamine (Chlorphenamine maleate 10mg/ml, Wockhardt UK Ltd, UK) given 
intravenously prior to premedication, and 2mg/kg of marbofloxacin (Marbocyl 200mg powder 
and solvent for injection, Vetoquinol UK Ltd, UK) as prophylactic antibiosis.
Case 2: Subjectively the patient required higher doses of analgesics to maintain an 
appropriate depth of anaesthesia, otherwise the rest of anaesthesia and recovery was 
uneventful.
DISCUSSION Include a very brief review of similar published cases 
This is the first case report to describe anaphylaxis from cefuroxime administration in dogs, 
and only the second in the veterinary literature of an adverse reaction. Anaphylaxis can be 
described as immunologic (immune complex or compliment mediated) or non-immunologic 
(direct mast cell or basophil degranulation) (18, 19). Previously classification included types 
I, II, III (known respectively as anaphylactic, cytotoxic, immune complex) and type IV or 
delayed cell mediated hypersensitivity. However, pathophysiology is complex and clinically 
they are indistinguishable. Both immunologic and non-immunologic anaphylaxis result in 
systemic clinical signs including severe bronchospasm, laryngeal oedema, respiratory failure, 
hypotension and cardiovascular collapse (17). No evidence of previous administration of IV 
cefuroxime or oral cephalosporin could be found on the referring vet history for either 
patient, making a non-immunologic reaction most likely. The cases we describe meets these 
specifications, and using the World Allergy Organisation (WAO) grading scale (table 4) the 
first case would be graded as “5c; severe bronchospasm; 10 minutes” and the second case 
“5z; tachypnoea; 10 minutes”. Treatment is symptomatic, and varies with severity of clinical 
signs (20, 21). Due to lack of clinical trials in animals, these treatment options have been 
taken from human medicine (18, 19, 22), which include epinephrine, intravenous fluid 
resuscitation, supplemental oxygen and cardiopulmonary support. Antihistamines and 
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glucocorticoids are not advised as first line treatments for anaphylaxis in human medicine 
due to lack of evidence of benefit (22, 23). 
The cases we describe here were managed differently from one another, and in part from the 
human guidelines above. Case 1 initially received terbutaline due to the presenting sign of 
bronchospasm – however despite seeing an improvement in oxygen saturation, chest 
compliance remained poor and adrenaline was administered slowly IV 5 minutes later. If an 
improvement in oxygen saturation had not been evident quickly, the decision to give 
adrenaline would have been made earlier – as it is key in these situations to not delay 
further therapy if the patient continues to deteriorate. With hindsight, adrenaline would have 
been the first line treatment of choice in this patient, although its use is not without risk. 
Adrenaline administration IV has a multitude of systemic effects due to actions on the α1, 
α2, β1 and β2 receptors including bronchodilation and peripheral vasoconstriction (therefore 
indicated in case 1 with suspected bronchoconstriction and hypotension). Via the same 
mechanisms adrenaline administration can result in significant tachycardia (in excess of 180 
beats per minute), cardiac arrhythmias and hypertension, however these effects are short 
lived (approximately 5-10 minutes). The adrenaline was diluted by a factor of 10 to allow 
slower administration, and no adverse drug effects were seen. Case 2 received IV 
chlorphenamine as first line treatment, which is contradictory to human guidelines, as 
histamine is one of many inflammatory mediators released in anaphylaxis, and it has no α or 
β agonist action unlike adrenaline. Chlorphenamine can cause mild hypotension when 
administered IV but otherwise causes few adverse effects; therefore risk of iatrogenic harm 
is low (compared to adrenaline). However once again it is important to stress that although 
improvement in clinical signs were seen in this case after chlorphenamine, if that had not 
occurred then it is critical to quickly reassess and change the treatment plan as needed, to 
avoid valuable time being lost as the patient deteriorates. The difference between this case 
and the previous is that oxygen saturation remained normal; as if this had not been the case 
it would have been a trigger for more aggressive therapy to be initiated. The improvement 
seen in case 2 after chlorphenamine alone could be due to various reasons, the first being 
possibly a reduced severity of reaction due to the patient not receiving the total prescribed 
dose. The cefuroxime was also administered at a slower rate in the second case, and 
through the injection port of the fluid giving set. This could have resulted in the reaction 
being detected sooner. Early detection therefore may have resulted in chlorphenamine 
administration limiting further histamine release, and a less severe effect. H1-antihistamines 
act as inverse agonists, alongside having inhibitory effects on inflammatory cell accumulation 
(24). Therefore, it may be possible that these anti-inflammatory effects were enough to 
mitigate the reaction, if it was immunologic as opposed to non-immunologic. 
The other adverse event reported in the literature by Gosling (2017) (4) was in a dog 
enrolled in a study that compared the incidence of adverse reactions to two antibiotics 
commonly used perioperatively (Zinacef and Augmentin, GlaxoSmithKline). The dog was 
reported to become mildly hypotensive post cefuroxime administration (systolic arterial 
blood pressure 88mmHg), which responded to intravenous fluid therapy alone. Prophylactic 
and perioperative antimicrobial administration is advocated to reduce risk of surgical site 
infections (SSI’s) (25-27). However the cause is often multifactorial and antimicrobial 
administration is one of many recommendations designed to be implemented together to 
reduce SSI risk (25), which can be damaging to patient welfare, prognosis and will also 
increase cost of veterinary treatment (28). Current veterinary guidelines recommend IV 
perioperative antimicrobial administration within 60 minutes before surgical incision, for 
procedures expected to last greater than 90 minutes (29). The BSAVA guide to responsible 
use of antibacterials lists amoxicillin/clavulanate or cefuroxime as agents for surgical use 
(29). However, neither of these exist in a licenced form for intravenous administration in 
veterinary patients, therefore must be prescribed under the cascade. In both cases (and as 
is standard at our institution) the cefuroxime was reconstituted as per the human datasheet, 
however there are no specific guidelines regarding speed of administration or concentration 
to be used. Although adverse events of unlicensed medicines can still be reported to the 
Veterinary Medicines Directorate, this does give potential for under-reporting of adverse 
events, with no veterinary drug manufacturer to investigate incidence. 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field
● Anaphylaxis can occur after administration of any drug, and can be life threatening.
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● Slow administration of drugs can prevent the full dose being given if an adverse reaction is 
identified early, potentially limiting the severity.
● A crash box with emergency drugs and a quick reference dose chart aids rapid decision-
making and treatment (30).
● Reporting of any adverse events to the Veterinary Medicines Directorate (VMD) is key to 
add to the small amount of veterinary literature in this area.
● Adverse drug events can be reported online via the VMD website: 
https://www.gov.uk/report-veterinary-medicine-problem
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Suspected trigger for 
anaphylaxis
Number of dogs Reference 
number
Amoxicillin clavulanate 17 (3),(4)
Cefuroxime
Cefazolin
3* (2 cases in this case report)
2
(4)
(5),(6)
Galidium based contrast 3 (7)
Ionic iodinated contrast 2 (8)
Sodium thiopental 2 (11),(12)
Buprenorphine 1 (9)
Rocuronium 1 (13)
Table 1: Summary of all reports found relating to specific drug related anaphylaxis 
in the veterinary literature. 
Sam
ple
pH PaCO2 PaO2 BE SpO
2 %
HCO
3
Na
+
K+ Cl- AnGa
p
A-a O2 
gradien
t
FiO
2 %
A 7.12 76 237 -9 100 22.6 158 5 11
5
25.7 309.7 90
B 7.16 66 401 -
8.
2
100 21.8 156 3.
9
11
4
24.2 158.2 90
C 7.39 28 114 -
6.
3
98 15.9 159 2.
8
12
2
24 0.7 21
Table 2: Arterial blood gas results taken from the first case described.
Units: PaCO2, PaO2 and A-a gradient in mmHg; BE, HCO3, Na+, K+, Cl- and anion gap 
in mmol/L. A-a O2 gradient calculated using the alveolar gas equation (31)
GA for CT imaging GA for surgery 
(adverse event)
GA for surgery, 
successful
Premedication Acepromazine, 
butorphanol
Methadone, 
dexmedetomidine
Methadone, 
dexmedetomidine
Induction Propofol Propofol Propofol
Other drugs Iodinated contrast 
agent
Cefuroxime, 
terbutaline*, 
adrenaline*, 
dexamethasone*.
*Administered after 
adverse event
Chlorphenamine, 
marbofloxacin, 
atipamizole, 
Epidural 
(preservative free 
morphine and 
bupivacaine), 
glycopyrollate, 
fentanyl, 
rocuronium, 
acepromazine, 
neostigmine.
Table 3: Summary of drugs administered to the first described case during three 
anaesthetics at the hospital.
Grade 1 Grade 2 Grade 3 Grade 4 Grade 5
Anaphylaxis
Symptom(s)/sig
n(s) from 1 
organ system 
Symptom(s)/sig
n(s) from 2 
organ 
Lower airway 
● Mild 
bronchospasm, 
Lower airway
● Severe 
bronchospasm, 
Lower or upper 
airway
● Respiratory 
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present 
Cutaneous 
● Urticaria 
and/or 
erythema 
warmth and/or 
pruritus, other 
than localized at 
the injection 
site 
And/or
● Tingling, or 
itching of the 
lips or
● Angioedema 
(not laryngeal)
Or 
Upper 
respiratory 
● Nasal 
symptoms (e.g., 
sneezing, 
rhinorrea, nasal 
pruritus, and/or 
nasal 
congestion)
And/or 
● Throat-
clearing (itchy 
throat)
And/or
● Cough not 
related to 
bronchospasm
Or 
Conjunctival 
● Erythema, 
pruritus, or 
tearing 
Or 
Other 
● Nausea 
● Metallic taste
symptoms listed 
in grade 1
e.g., cough, 
wheezing, 
shortness of 
breath which 
responds to 
treatment 
And/or 
Gastrointestinal
● Abdominal 
cramps and/or 
vomiting/diarrh
oea
 
Other 
● Uterine 
cramps 
● Any 
symptom(s)/sig
n(s) from grade 
1 would be 
included
e.g., not 
responding or 
worsening in 
spite of 
treatment
And/or 
Upper airway
● Laryngeal 
oedema with 
stridor 
● Any 
symptom(s)/sig
n(s) from 
grades 1 or 3 
would be 
included
failure and/or
Cardiovascular
●Collapse/hypot
ension† 
And/or 
● Loss of 
consciousness 
(vasovagal 
excluded) 
● Any 
symptom(s)/ 
sign(s) from 
grades 1, 3, or 
4 would be 
included
The final grade of the reaction is not determined until the event is over, regardless of the 
medication administered to treat the reaction. The final report should include the first 
symptom(s)/sign(s) and the time of onset after the causative agent exposure and a suffix 
reflecting if and when epinephrine was or was not administered: a, <5 min; b, >5 min to 
<10 min; c, >10 to <20 min; d, >20 min; z, epinephrine not administered. Final report: 
Grade 1-5; a-d, or z; First symptom(s)/sign(s); Time of onset of first symptom(s)/signs(s)
Table 4: Modification of the 2010 WAO grading system (17). 
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